We report a case of a 25-year-old lady who presented to our department with complaints of easy fatigability and shortness of breath since one week. She had a history of Raynaud's phenomenon. Examination revealed scleroderma like skin changes and pericardial friction rub. Investigations revealed high titer of anti-U1 RNP antibodies along with co-existing pancytopenia. Chest x-ray and echocardiography confirmed pericardial tamponade. Patient was diagnosed as having mixed connective tissue disorder (MCTD) and she was started on high dose prednisolone, which led to complete reversal of pancytopenia and pericardial tamponade after 1 month of treatment. There are only 6 reported cases of pericardial tamponade in a patient with MCTD, and none of them had pancytopenia. Present case highlights the need to investigate the patient of pericardial tamponade for MCTD, especially in the presence of pancytopenia and relevant clinical history, as prompt treatment with corticosteroids can avoid invasive procedures like pericardiocentesis.
Case Report
We report a case of a 25-year old lady who presented to our OPD with the complaints of generalized body swelling since one month and shortness of breath since one week. Patient was well one month back when she started developing swelling over the body which she noticed first on face and gradually progressed to involve the whole body which was associated with the simultaneous thickening of the overlying skin and appearance of depigmented lesions over the hands and back. She developed increasing difficulty in breathing since the last one week which was associated with fever and chest pain for which she presented to our OPD. Patient was a married woman and had history of two consecutive abortions in the past and had no live issues. She had a 1 year history of Raynaud's phenomenon. There was no history of oral ulcers, arthralgias, arthritis, photosensitivity, facial erythema, jaundice, malena, hemetemesis, reduced urine output, hematuria and family history of autoimmune disease. On examination, patient was conscious and oriented to time, place and person and was afebrile to touch. Her BP was 110/60 mmHg and pulse rate was 108/min. General physical examination was remarkable for the presence of pallor, but there was no icterus, cyanosis, clubbing or lymphadenopathy. Patient's JVP was raised and she had bilateral pitting type of pedal edema and periorbital edema. There was thickening and diffuse pigmentation of skin over both the limbs, with perifollicular depigmented macules seen over the arms and back, nonscarring alopecia, and reduced mouth opening ( Figure 1 ). Dorsum of bilateral hands had puffy appearance with loss of wrinkles and dermal appendages. Cardiovascular examination revealed the presence of pericardial friction rub. Respiratory, abdominal and central nervous system examination were unremarkable.
Patient's routine investigations revealed: Hb 78 gm/L; total leucocyte count 3700×10 9 /L; differential count; 52% polymorphs; 41% lymphocytes; 4% eosinophils; 3% monocytes; platelet counts 40×10 9 /L. Peripheral smear revealed pancytopenia with normocytic and normochromic anemia. Erythrocyte sedimentation rate 65 mm/hr, liver and kidney function tests were normal, total calcium 1. 
Discussion
Mixed connective tissue disorder was first described by Sharp et al. in 1972 as an overlap syndrome with features of SLE, systemic sclerosis and polymyositis along with the presence of high titers of anti-U1RNP antibodies. 1 Since then, MCTD has been characterized in a better way and is known to evolve from one subtype into another. A number of autoantibodies are reported in MCTD which includes anti-U1 RNP (IgG subtype), anti-ACE2, anti-cardiolipin, antiendothelial cell antibody, and others including anti-Ro/SS-A, anti-Sm, anti-ssDNA, anti-dsDNA, although not specific for MCTD. 2 Cardiac involvement in MCTD has been reported widely from 11-85% depending on the method used for detection. 3, 4 Alpert et al. reported a number of cardiac abnormalities in MCTD including pericarditis (with or without effusions, 29%), mitral valve prolapse (10%), cardiac conduction abnormalities, myocarditis, intimal hyperplasia of the intramural coronary arteries, perivascular leucocytic infiltrates and pulmonary artery hypertension. 4 Pericarditis is the commonest cardiac manifestation of MCTD variably reported to occur in 29%, 43%, 56% of the cases, detected either ante-mortem or by autopsy. [4] [5] [6] Pericardial effusions are found in 24-38% of the patients by echocardiography. 4 o n l y involvement in MCTD is usually asymptomatic and clinically significant disease is present in only 10% of cases. Even rarer in MCTD is tamponade which has been reported in only 6 cases till date, usually in the setting of an established disease. Pericardial tamponade can present acutely with sudden deterioration of the condition or sub-acutely with gradually progressive features. Pathogenesis of pericarditis in MCTD is unknown but has been proposed to be complement mediated. 8 Treatment of pericardial disease in MCTD is not established however, literature provides evidence of effectiveness of NSAIDS, colchicines, corticosteroids, and immunosuppressant in the management of pericarditis associated with MCTD. 9 Complete resolution of pericardial effusions has been reported with the use of corticosteroids. Hematological manifestations in MCTD includes anemia of chronic disease, leucopenia, coomb's positive hemolytic anemia, 10 pure red cell aplasia. 11 Thrombocytopenia has been described in MCTD and causes can be IgG antiplatelet antibody mediated platelet destruction, 12 thrombotic thrombocytopenic purpura, 13 or antiphospholipid antibody syndrome. Antiphospholipid antibodies have been seen in 15% of the patients with MCTD (different from anti-b2GP1) and are associated with pulmonary artery hypertension but are usually not associated with thrombotic eventsalthough, 2,14 case reports of sinus vein thrombosis due to antiphospholipid antibody syndrome in MCTD have been described in the literature. 15 Pancytopenia is a very rare finding in MCTD and is even rarer as a first manifestation. Kumar et al. 9 reported a case of pericardial tamponade in MCTD along with review of the 5 previously reported cases, making a total of 6 reported cases till date. Pericardial tamponade is reported in only 1 case as a first presentation of the disease, 4 cases required invasive procedure (pericardiocentesis or pericardiostomy) in combination with corticosteroids for the treatment, 1 case was managed with only corticosteroids and 1 was treated successfully with only NSAIDS. None of the 6 reported cases had pancytopenia at presentation or at any point of time. Our patient presented with pericardial tamponade and pancytopenia was detected on investigations. Diagnosis of MCTD was made by criteria proposed by Kasukawa et al. 6 Patient was treated with high dose corticosteroids for 1 month with complete normalization of blood counts and resolution of pericardial effusion. We probably report the first case of pericardial tamponade with pancytopenia as the first presentation of MCTD, which completely recovered with only corticosteroids, without any invasive intervention.
Conclusions
Mixed connective tissue disorder is an overlap syndrome of scleroderma, SLE and polymyositis. Pericardial tamponade although rare, has been reported in this disorder and represents a potentially fatal complication. Present case highlights the fact that cardiac tamponade can be the initial presentation of the MCTD. Prompt recognition of the underlying MCTD as the cause of pericardial tamponade is a key in the management and timely treatment with corticosteroids can effectively reverse this fatal condition. Similarly, pancytopenia is a rare finding in MCTD and presence of pancytopenia in a patient with pericardial tamponade should make a clinician to direct his diagnosis towards mixed connective tissue disorder under appropriate clinical scenario.
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